|
|
|
Insider
Information: |
Sandler Andrew Seth |
Relationship: |
|
City: |
Seattle |
State: |
WA |
|
|
Insider
Summary: |
|
|
|
Companies Owned : |
2 |
|
Direct
Shares |
232,098 |
|
Indirect Shares
|
0 |
|
|
Direct
Value |
$0 |
|
|
Indirect Value
|
$0 |
|
|
Total
Shares |
232,098 |
|
|
Total
Value |
$0 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
Total
Filings :
|
0
|
0
|
Stock
price went up :
|
0
|
0
|
Stock
price went down : |
0
|
0
|
|
|
|
Gain/Loss Ratio : |
0.0
|
0.0
|
Percentage
Gain/Loss : |
0.0%
|
0.0%
|
|
|
|
|
|
|
Holdings
:
Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold |
|
Dendreon Corp |
DNDN |
EVP, Chief Medical Off... |
2015-02-13 |
207,914 |
2014-01-13 |
0 |
Premium* |
|
Dermata Therapeutics, Inc. |
DRMA |
|
2022-10-06 |
24,184 |
2022-04-07 |
0 |
Premium* |
|
|
|
|
|
|
|
|
|
|
Records found :
19 |
Free Registration Required For Full Results. Limit: 25
|
|
Download |
Page 1 of 1
|
Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
3m +/- |
|
|
Form |
DNDN |
Dendreon Corp |
EVP, Chief Medical Officer |
|
2014-01-13 |
4 |
A |
$0.00 |
$0 |
D/D |
75,000 |
349,184 |
0 |
- |
|
DRMA |
Dermata Therapeutics, Inc... |
Director |
|
2022-04-07 |
4 |
A |
$0.00 |
$0 |
D/D |
5,190 |
5,190 |
0 |
- |
|
DRMA |
Dermata Therapeutics, Inc... |
|
|
2022-07-07 |
4 |
A |
$0.00 |
$0 |
D/D |
8,874 |
14,064 |
0 |
- |
|
DRMA |
Dermata Therapeutics, Inc... |
|
|
2022-10-06 |
4 |
A |
$0.00 |
$0 |
D/D |
10,120 |
24,184 |
0 |
- |
|
DNDN |
Dendreon Corp |
EVP, Chief Medical Officer |
|
2014-01-29 |
4 |
D |
$2.79 |
$299 |
D/D |
(107) |
349,077 |
0 |
- |
|
DNDN |
Dendreon Corp |
EVP, Chief Medical Officer |
|
2014-04-03 |
4 |
D |
$2.93 |
$3,783 |
D/D |
(1,291) |
347,786 |
0 |
- |
|
DNDN |
Dendreon Corp |
EVP, Chief Medical Officer |
|
2014-04-09 |
4 |
D |
$2.90 |
$3,718 |
D/D |
(1,282) |
346,504 |
0 |
- |
|
DNDN |
Dendreon Corp |
EVP, Chief Medical Officer |
|
2014-04-29 |
4 |
D |
$2.53 |
$281 |
D/D |
(111) |
346,393 |
0 |
- |
|
DNDN |
Dendreon Corp |
EVP, Chief Medical Officer |
|
2014-07-03 |
4 |
D |
$2.29 |
$2,956 |
D/D |
(1,291) |
345,102 |
0 |
- |
|
DNDN |
Dendreon Corp |
EVP, Chief Medical Officer |
|
2014-07-09 |
4 |
D |
$2.27 |
$2,908 |
D/D |
(1,281) |
343,821 |
0 |
- |
|
DNDN |
Dendreon Corp |
EVP, Chief Medical Officer |
|
2014-07-29 |
4 |
D |
$2.10 |
$233 |
D/D |
(111) |
343,710 |
0 |
- |
|
DNDN |
Dendreon Corp |
EVP, Chief Medical Officer |
|
2014-10-03 |
4 |
D |
$1.36 |
$1,756 |
D/D |
(1,291) |
342,419 |
0 |
- |
|
DNDN |
Dendreon Corp |
EVP, Chief Medical Officer |
|
2014-10-09 |
4 |
D |
$1.02 |
$1,308 |
D/D |
(1,282) |
341,137 |
0 |
- |
|
DNDN |
Dendreon Corp |
EVP, Chief Medical Officer |
|
2014-10-29 |
4 |
D |
$1.03 |
$114 |
D/D |
(111) |
341,026 |
0 |
- |
|
DNDN |
Dendreon Corp |
EVP, Chief Medical Officer |
|
2015-01-03 |
4 |
D |
$0.08 |
$902 |
D/D |
(11,745) |
329,281 |
0 |
- |
|
DNDN |
Dendreon Corp |
EVP, Chief Medical Officer |
|
2015-01-09 |
4 |
D |
$0.08 |
$125 |
D/D |
(1,530) |
327,751 |
0 |
- |
|
DNDN |
Dendreon Corp |
EVP, Chief Medical Officer |
|
2015-01-13 |
4 |
D |
$0.09 |
$533 |
D/D |
(6,121) |
321,630 |
0 |
- |
|
DNDN |
Dendreon Corp |
EVP, Chief Medical OfficerOffi |
|
2014-01-13 |
3 |
IO |
$0.00 |
$0 |
D/D |
0 |
274,184 |
|
- |
|
DNDN |
Dendreon Corp |
EVP, Chief Medical Officer |
|
2015-02-13 |
4 |
S |
$0.09 |
$10,174 |
D/D |
(113,716) |
207,914 |
0 |
- |
|
19 Records found
|
1
|
Page 1 of 1 |
|
Free Registration Required For Full Results. Limit: 25
|
|
|
Transaction Code Key: |
Ownership Code Key |
|
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
|
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
|
IO |
- Initital Ownership |
D |
- Disposed |
|
|
|
|
|
|